0 items USD 0.00Search
Your search for "delveinsight selective cox inhibitors pipeline insights 2016" gave back 50060 results.
Market Analysis and Insights: Global Selective Cox-2 Inhibitors Market The global Selective Cox-2 Inhibitors market is projected to grow from US$...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The “Selective Cox-2 Inhibitors Industry Forecast” looks at past sales and reviews total world Selective Cox-2 Inhibitors sales in 2022, providing a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Highlights The global Selective Cox-2 Inhibitors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
COX inhibitors are mostly antipyretic and analgesic anti-inflammatory drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs). COX-2 has...
Catalog:
LPI
February 2023
Price: USD 3,660.00
COX inhibitors are mostly antipyretic and analgesic anti-inflammatory drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs). COX-2 has...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Competitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment This industry report describes the competitive R&D...
Catalog:
La Merie Publishing
December 2016
Price: USD 220.00
COX inhibitors are mostly antipyretic and analgesic anti-inflammatory drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs). COX-2 has...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Competitor Analysis: PD-1 and PD-L1 Immune Checkpoint Inhibitors 2016 This Competitive Intelligence report about PD-1 and PD-L1 Immune Checkpoint...
Catalog:
La Merie Publishing
October 2016
Price: USD 450.00
Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology This product consists of four reports in pdf format describing...
Catalog:
La Merie Publishing
December 2016
Price: USD 1,386.00
Competitor Analysis: TGF-β Inhibitors for Modulation of the Tumor Microenvironment This industry report describes the competitive R&D landscape...
Catalog:
La Merie Publishing
December 2016
Price: USD 220.00
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β/R, CXCR4, CSF-1R, CD47-SIRPα, Adenosine, STING & Others This Competitive...
Catalog:
La Merie Publishing
December 2016
Price: USD 770.00
Competitor Analysis: Inhibitors of Negative Immune Checkpoints CTLA-4, LAG-3, TIM-3 & Others This Competitive Intelligence report about...
Catalog:
La Merie Publishing
November 2016
Price: USD 550.00
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities The field of oncolytic viruses...
Catalog:
La Merie Publishing
January 2017
Price: USD 2,400.00
